Back to Search Start Over

Safety and efficacy of Nutrase P (6-phytase) for chickens for fattening, other poultry for fattening, reared for laying and ornamental birds

Authors :
Maria Saarela
Baltasar Mayo
Maria de Lourdes Bastos
Mojca Fašmon Durjava
Maryline Kouba
Matteo Lorenzo Innocenti
Elisa Pettenati
Fernando Ramos
Vasileios Bampidis
Gloria López-Gálvez
Giovanna Azimonti
Miguel Prieto
Henrik Christensen
Boet Glandorf
Francesca Marcon
Secundino López Puente
Marta López-Alonso
Jaume Galobart
Lieve Herman
Montserrat Anguita
Rosella Brozzi
Maria Vittoria Vettori
Mariana Petkova
Guido Rychen
Alena Pechová
Birgit Dusemund
Roberto Edoardo Villa
Efsa Panel on Additives
Konstantinos Sofianidis
Yolanda Sanz
Pier Sandro Cocconcelli
Lucilla Gregoretti
Ruud Woutersen
Source :
EFSA Journal, EFSA Journal, Vol 18, Iss 11, Pp n/a-n/a (2020)
Publication Year :
2020

Abstract

Nutrase P is available in powder, granulated, thermostable granulate and liquid forms. It is based on a 6‐phytase produced by a genetically modified strain of K. phaffii. The production strain contains four copies of the ampicillin resistance gene and one copy of a bleomycin resistance gene. Although Nutrase PTS 10,000 (thermostable granulate) and Nutrase PG 10,000 (granulate) do not raise concern regarding the presence of viable cells of the production strain and its recombinant DNA, uncertainties remain on the presence of viable cells and DNA of the production strain in Nutrase PL 10,000 (liquid) and Nutrase PD 100,000 (powder). The FEEDAP Panel cannot conclude on the safety of the additive, in any form, for the target species for which application is made due to major limitations in the study in chickens for fattening provided. Considering the production strain and the results obtained in the genotoxicity studies, the Panel concludes that additive does not pose a toxicological safety concern regarding the consumers of the products obtained from animals receiving the additive. The additive, in its all formulations, is not a skin or eye irritant and is not dermal sensitiser. However, owing to the proteinaceous nature of the active substance it should be considered a respiratory sensitiser. The active substance of the additive is a protein and as such would not raise concerns for the environment. Considering that the production strain harbours AMR genes and there is uncertainties regarding the presence of viable cells and DNA of the production strain in Nutrase PL 10,000 (liquid) and Nutrase PD 100,000 (powder), the Panel cannot conclude on the safety of these two formulations of the additive for the target species, consumer, user and environment. Owing to the lack of data, the FEEDAP Panel cannot conclude on the efficacy of the additive.

Details

ISSN :
18314732
Volume :
18
Issue :
11
Database :
OpenAIRE
Journal :
EFSA journal. European Food Safety Authority
Accession number :
edsair.doi.dedup.....593c922ce48177c98aaf79841cc54f15